Tags: FDA | drugs | radiation exposure | nuclear attack survival

FDA to Assess Drugs That Treat Radiation Exposure

Thursday, 02 May 2013 08:22 AM

Drugs from Amgen Inc, Teva Pharmaceutical Industries and Sanofi that boost white blood cells are being evaluated by U.S. regulators as treatments for radiation exposure caused by a nuclear attack or accident.
The drugs, known as leukocyte growth factors, will be the subject of a Friday meeting of an advisory committee to the U.S. Food and Drug Administration.
 
Treatment with Amgen's Neupogen and Neulasta, Teva's Tbo-filgrastim and Sanofi's Leukine, may decrease death rates from radiation exposure, according to FDA staff documents released ahead of the meeting.
 
Neupogen, which like the other drugs in the class is given by injection, has been tested in monkeys exposed to radiation by researchers at the National Institutes of Health and the University of Maryland.
 
Friday's hearing was prompted by data from the trial showing that the drug reduced mortality following lethal irradiation of the animals.
 
Amgen spokeswoman Ashleigh Koss said the company provided additional nonclinical data from studies using the drugs in radiation-exposed animals, and an overview of literature case studies of their use in victims of radiological accidents.
 
She declined to comment on whether Amgen planned to participate in any future trials of Neupogen or Neulasta as treatments for radiation exposure.
 
The Amgen drugs, currently used to reduce the risk of infection for cancer patients undergoing chemotherapy, had 2012 sales of $5.4 billion.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Drugs from Amgen Inc, Teva Pharmaceutical Industries and Sanofi that boost white blood cells are being evaluated by U.S. regulators as treatments for radiation exposure caused by a nuclear attack or accident.The drugs, known as leukocyte growth factors, will be the subject of...
FDA,drugs,radiation exposure,nuclear attack survival
220
2013-22-02
Thursday, 02 May 2013 08:22 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved